Transdermal Immunization with Microparticulate RSV-F Virus-like Particles Elicits Robust Immunity

No approved vaccines against respiratory syncytial virus (RSV) infections exist to date, due to challenges arising during vaccine development. There is an unmet need to explore novel approaches and a universal strategy to prevent RSV infections. Previous studies have proven the immune efficacy of vi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sucheta D’Sa, Kimberly Braz Gomes, Grace Lovia Allotey-Babington, Cemil Boyoglu, Sang-Moo Kang, Martin J. D’Souza
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2022-04-01
Colecção:Vaccines
Assuntos:
RSV
virus-like particles (VLPs)
transdermal
microparticles
Acesso em linha:https://www.mdpi.com/2076-393X/10/4/584
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados